Steven Cohen Cv Rx, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.99 - $30.49 $3.18 Million - $5.38 Million	176,518 Added 943.95%	195,218 $3.55 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $33.01 $218,229 - $617,287	18,700 New	18,700 $587,000
Q1 2023 May 15, 2023	BUY	$7.08 - $19.4 $20,100 - $55,076	2,839 New	2,839 $26,000
Q3 2021 Nov 15, 2021	SELL	$14.65 - $26.07 $380,900 - $677,820	-26,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $728,000 - $728,000	26,000 New	26,000 $728,000

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $231M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.